Skip to Content

Jury Awards Novartis Women $250 Million

From UPI Business News (May 19, 2010)

A jury in Manhattan ordered Swiss pharmaceutical giant Novartis to pay 5,600 plaintiffs in a sex discrimination case $250 million in damages.

The award in the class-action case was the second this week. Twelve women who pioneered the case against the drug company were awarded $3.3 million in damages earlier this week, ABC News reported Wednesday.

Wednesday’s award may not be the last or the biggest in the case. A jury is to decide whether Novartis underpaid women and, if so, how much the company should pay to compensate the 5,600 plaintiffs for that.

Andy Wyss, president of Novartis Pharmaceuticals Corp, said "for more than 10 years the company has developed and implemented policies setting high standards with regards to diversity and inclusion."

He said "we are disappointed in the jury’s verdict."

An attorney for the plaintiffs, David Sanford, said the awards "sent a message to Novartis and all other corporations in America that they cannot continue to get away with the discrimination."


Posted: May 2010